Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age. It is characterized by a variety of symptoms, including irregular menstrual cycles, infertility, obesity, hirsutism, acne, and insulin resistance. PCOS is a complex disorder, and its pathogenesis remains largely unknown. Despite its prevalence, PCOS is often underdiagnosed or misdiagnosed due to the lack of a clear diagnostic criteria. This article aims to provide an overview of PCOS and its management, in order to help physicians better recognize and treat the disorder.
PCOS is a heterogeneous disorder with variable presentations. It is characterized by anovulation, hyperandrogenism, and polycystic ovarian morphology. Anovulation is defined as the absence of ovulation, and is the most common symptom of PCOS. Hyperandrogenism is the presence of elevated androgens, such as testosterone, in the blood. Polycystic ovarian morphology is the presence of multiple small cysts in the ovaries, which can be seen on ultrasound.
The diagnosis of PCOS is based on the presence of two of the three criteria: anovulation, hyperandrogenism, and polycystic ovarian morphology. Anovulation can be diagnosed by a history of irregular menstrual cycles, or by monitoring for ovulation with basal body temperature or urinary luteinizing hormone (LH) tests. Hyperandrogenism can be diagnosed by measuring serum testosterone and other androgens. Polycystic ovarian morphology can be diagnosed by transvaginal ultrasound.
PCOS is associated with a number of complications, including infertility, obesity, hirsutism, acne, and insulin resistance. Infertility is the most common complication of PCOS, and is caused by the lack of ovulation. Obesity is also common in PCOS, and is thought to be due to insulin resistance. Hirsutism, acne, and insulin resistance can also be caused by the elevated androgens associated with PCOS.
The management of PCOS depends on the patient's individual presentation and goals. For those with fertility issues, ovulation induction with drugs such as clomiphene citrate or gonadotropins may be recommended. For those with hirsutism, acne, or obesity, lifestyle modifications such as diet and exercise as well as medications such as metformin or spironolactone may be recommended.
PCOS is a complex disorder that affects many women of reproductive age. It is characterized by anovulation, hyperandrogenism, and polycystic ovarian morphology, and is associated with a number of complications, including infertility, obesity, hirsutism, acne, and insulin resistance. The diagnosis of PCOS is based on the presence of two of the three criteria, and the management of PCOS depends on the patient's individual presentation and goals. With a better understanding of PCOS and its management, physicians can help women better recognize and treat the disorder.
1.
The use of biomarkers in the treatment of breast lumps is at a crossroads.
2.
According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.
3.
How Do Younger People Fare With Stool Tests for CRC Screening?
4.
Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL
5.
Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer
1.
How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies
2.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
3.
Introduction to Immune Thrombocytopenic Purpura
4.
Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer
5.
The Different Types of Cysts and Why They Occur: Insights from a Dermatologist
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
2.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
3.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Navigating the Complexities of Ph Negative ALL - Part XII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation